These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 11890564)
1. Antidepressant dosing and switching guidelines: focus on nefazodone. Zajecka J; McEnany GW; Lusk KM J Clin Psychiatry; 2002; 63 Suppl 1():42-7. PubMed ID: 11890564 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic dose range of nefazodone in the treatment of major depression. Robinson DS; Marcus RN; Archibald DG; Hardy SA J Clin Psychiatry; 1996; 57 Suppl 2():6-9. PubMed ID: 8626365 [TBL] [Abstract][Full Text] [Related]
3. The safety profile of nefazodone. Robinson DS; Roberts DL; Smith JM; Stringfellow JC; Kaplita SB; Seminara JA; Marcus RN J Clin Psychiatry; 1996; 57 Suppl 2():31-8. PubMed ID: 8626361 [TBL] [Abstract][Full Text] [Related]
4. Nefazodone: single versus twice daily dose. Voris JC; Shaurette GN; Sebastian PS; Will-Wallace LA Pharmacotherapy; 1998; 18(2):379-80. PubMed ID: 9545158 [TBL] [Abstract][Full Text] [Related]
8. Long-term treatment of depression with nefazodone. Anton SF; Robinson DS; Roberts DL; Kensler TT; English PA; Archibald DG Psychopharmacol Bull; 1994; 30(2):165-9. PubMed ID: 7831450 [TBL] [Abstract][Full Text] [Related]
9. The antidepressant nefazodone. A review of its pharmacology, clinical efficacy, adverse effects, dosage, and administration. Khouzam HR J Psychosoc Nurs Ment Health Serv; 2000 Aug; 38(8):20-5. PubMed ID: 10959472 [TBL] [Abstract][Full Text] [Related]
12. Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression. Davis R; Whittington R; Bryson HM Drugs; 1997 Apr; 53(4):608-36. PubMed ID: 9098663 [TBL] [Abstract][Full Text] [Related]
13. Nefazodone relief of alprazolam interdose dysphoria: a potential therapeutic benefit of 3A3/4 inhibition. Ketter TA; Callahan AM; Post R J Clin Psychiatry; 1996 Jul; 57(7):307. PubMed ID: 8666573 [No Abstract] [Full Text] [Related]
14. Nefazodone treatment of cocaine dependence with comorbid depressive symptoms. Ciraulo DA; Knapp C; Rotrosen J; Sarid-Segal O; Ciraulo AM; LoCastro J; Greenblatt DJ; Leiderman D Addiction; 2005 Mar; 100 Suppl 1():23-31. PubMed ID: 15730347 [TBL] [Abstract][Full Text] [Related]
15. Placebo-controlled dose-ranging trial designs in phase II development of nefazodone. D'Amico MF; Roberts DL; Robinson DS; Schwiderski UE; Copp J Psychopharmacol Bull; 1990; 26(1):147-50. PubMed ID: 2196622 [TBL] [Abstract][Full Text] [Related]
16. [Nefazodone: a new antidepressive agent. Advantages of a dual working principle]. Nervenarzt; 1997 Jul; 68(7 Suppl Neues Anti):1-4. PubMed ID: 9431359 [No Abstract] [Full Text] [Related]